Activation of extracellular-signal regulated kinase is required for phagocytosis by Lymnaea stagnalis haemocytes  by Plows, Louise D et al.
www.bba-direct.com
Biochimica et Biophysica Acta 1692 (2004) 25–33Activation of extracellular-signal regulated kinase is required for
phagocytosis by Lymnaea stagnalis haemocytes
Louise D. Plows, Richard T. Cook, Angela J. Davies, Anthony J. Walker*
School of Life Sciences, Kingston University, Penrhyn Road, Kingston-Upon-Thames, Surrey, KT1 2EE, UKReceived 20 November 2003; received in revised form 30 January 2004; accepted 2 March 2004
Available online 19 March 2004Abstract
Haemocytes are the primary defence cells of molluscs. In the present study, extracellular-signal regulated kinase (ERK) 1/2-like proteins
were identified within Lymnaea stagnalis haemocytes, with apparent molecular weights of 44 and 43 kDa, respectively. Mitogen-activated
protein kinase (MAPK) activity assays have confirmed that the L. stagnalis ERK possesses kinase activity towards Elk-1. Challenge of
haemocytes with bacterial lipopolysaccharide (LPS) resulted in a transient activation of ERK, and immunocytochemistry revealed that
phospho-ERK was present in both the perinuclear region and the nucleus following challenge. MAPK/ERK kinase (MEK) inhibitors blocked
ERK activation confirming that MEK lies upstream of ERK in haemocytes. Moreover, phagocytosis assays, using various inhibitors, showed
that ERK activity was vital for efficient phagocytosis and that ERK may be activated by both Ras-dependent and Ras-independent
mechanisms. Overall, this study has furthered knowledge of ERK signalling in molluscan immunity and has shown that the ERK pathway
regulates the phagocytic activity of molluscan haemocytes.
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The molluscan immune response comprises cellular and
humoral mechanisms that respond to invasion by micro-
organisms, other pathogens and parasites [1]. Haemocytes,
mobile immune cells that are functionally similar to mam-
malian macrophages, carry out the cellular response and
primarily act to endocytose, phagocytose or encapsulate
foreign material. These phagocytes are typically equipped
with recognition factors (lectins), lysosomal enzymes and a
cytotoxicity mechanism that uses reactive oxygen/nitrogen
intermediates [2–4]. Considering the importance of haemo-
cytes in the molluscan immune response it is surprising that
there have been few studies on the molecular basis of
haemocyte function.
Immune challenge of mammalian macrophages by cell-
free lipopolysaccharide (LPS) or bacteria is often accompa-
nied by activation of the highly conserved extracellular-0167-4889/$ - see front matter D 2004 Elsevier B.V. All rights reserved.
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positively or negatively regulate certain immune responses
such as phagocytosis [5–10]. The ERK pathway belongs to
the mitogen-activated protein kinase (MAPK) family, along
with the p38 and c-Jun N-terminal kinase (JNK) pathways.
The two ERK isozymes, p44 and p42 (commonly referred to
as ERK 1/2, respectively), are phosphorylated by MAPK/
ERK kinase (MEK) on threonine183 and tyrosine185 residues
and this dual phosphorylation leads to enzyme activation
[11]. MEK is activated in part through autophosphorylation
[12] and by the protein kinase, Raf, which is itself phos-
phorylated in either a Ras-dependent or Ras-independent
manner [13,14], which involves PKC [8,15], protein kinase
A (PKA) and PI-3-kinase [16]. Phosphorylated ERK 1/2 can
translocate to the nucleus, where it activates various tran-
scription factors including Elk-1 [17], and can also migrate
to cytosolic targets including cytoskeletal proteins [18–20].
Until recently, the signal transduction pathways involved
in immune responses such as phagocytosis by invertebrate
haemocytes have been largely uncharacterised. The ERK
pathway has been identified in haemocytes from the Med-
iterranean fruit fly Ceratitis capitata, along with the h3 cell-
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complex [21,22]. Moreover, the ERK pathway and h3
receptor have both been shown to be involved in the
attachment and internalisation of cell-free LPS and E. coli
by C. capitata haemocytes [21]. ERK and p38 MAPK
pathways have both been recently identified in haemocytes
from the bivalve mollusc, Mytilus galloprovincialis [23] and
PKC, ERK 1/2 and the h integrin subunit have been shown
to be present in the Biomphalaria glabrata embryonic (Bge)
cell line [24–26]. These cultured Bge cells appear to have
features in common with circulating haemocytes, such as
their ability to phagocytose and spread on glass/plastic
substrates [24]. An ERK homologue has also been reported
in the Drosophila S2 embryonic cell line [27].
We have recently reported that bacterial LPS modulates
the phosphorylation and activation of PKC in primary
haemocytes from the gastropod snail Lymnaea stagnalis
[28]. Moreover, recently it has been suggested that PKC
may be involved in phagocytosis by B. glabrata haemocytes
[29]. The present study focuses on the characterisation of
the ERK signalling pathway in L. stagnalis haemocytes and
its role in the molluscan immune response. Since previous
studies with mammalian macrophages have shown that
phagocytosis can be either dependent or independent of
ERK activation [5–10], this study aimed to clarify the role
of the ERK pathway in phagocytosis by haemocytes. The
presence of ERK 1/2-like immunoreactive proteins in L.
stagnalis haemocytes is demonstrated and phosphorylation
of ERK is shown to increase when the cells are challenged
with bacterial LPS. Moreover, by blocking MEK activity it
is shown that MEK lies upstream of ERK in L. stagnalis
haemocytes, and that the ERK pathway is directly involved
in phagocytosis of FITC-conjugated E. coli (‘‘bioparticles’’)
by these cells. To our knowledge, this is the first study that
has focused in detail on the molecular basis of phagocytosis
in primary haemocytes from L. stagnalis.2. Materials and methods
2.1. Materials
Anti-phospho-p44/42 MAPK, anti-p44/42 MAPK, anti-
phospho-MEK, and anti-phospho-Elk 1 polyclonal antibod-
ies, U0126 and the non-radioactive MAP kinase activity
assay kit, were purchased from New England Biolabs Inc.
(Beverly, USA). PD98059, anti-active MAPK and anti-ERK
1/2 polyclonal antibodies were from Promega (Southampton,
UK), whereas the anti-pan-ERK polyclonal antibody was
purchased from Transduction Laboratories (Lexington,
USA). Protogel [30% (w/v) acrylamide] was from National
Diagnostics (Hull, UK), and Hybond Nitrocellulose mem-
brane was from Amersham Biosciences (Amersham, UK).
The Opti-4CN detection kit and the DC protein assay kit were
both from Bio-Rad (Hemel Hempstead, UK). Vectashield
was purchased from Vector Laboratories (Peterborough,UK). LY294002 and FTase inhibitor I were from Calbiochem
(Nottingham, UK). E. coli LPS (serotype 0111:B4), molec-
ular weight markers (SDS-6H), FITC-conjugated E. coli
(‘‘bioparticles’’), FITC-conjugated goat-anti-rabbit second-
ary antibody, rhodamine phalloidin, GF109203X, protease
and phosphatase inhibitor cocktails, and all other chemicals
were purchased from Sigma (Poole, UK).
2.2. Animals
Laboratory cultures of L. stagnalis were reared from eggs
produced by adult snails purchased from Blades Biologicals
(Edenbridge, UK). Juvenile snails were kept at room tem-
perature until they reached a shell length of approx. 20–30
mm, they were then transferred to an incubator and kept
under a 12 h light–dark cycle at 20 jC. All tanks contained
continuously aerated water, which had been filtered through
a Brimak/carbon filtration unit (Silverline Ltd., Winkleigh,
UK). Snails were fed washed fresh lettuce ad libitum.
2.3. Extraction of L. stagnalis haemolymph
Adult L. stagnalis were washed with distilled water and
the haemolymph was extracted from the snails by head-foot
retraction [30]. Haemolymph was collected and kept on ice
in Sterile Snail Saline (SSS [2]; one part SSS: two parts
haemolymph). For total protein extracts, the diluted haemo-
lymph was centrifuged for 5 min at 800 g. The superna-
tant was then removed and the cell pellet was either
homogenised on ice in homogenisation buffer, containing
protease and phosphatase inhibitor cocktails at the manu-
facturers recommended strength, or was resuspended in
boiling SDS-PAGE sample buffer.
2.4. Challenge of haemocytes with E. coli LPS
Haemocyte monolayers were obtained by allowing cells to
adhere to individual wells (200 Al diluted haemolymph per
well) of a 24-well culture plate (Nunc) for 30 min at room
temperature. Monolayers were then washed three times with
SSS and were allowed to equilibrate for a further 15 min at
room temperature prior to the addition of E. coli LPS (1 or 10
Ag/ml) for various times (0–20 min). At the end of the
incubation period, cells were lysed with boiling SDS-PAGE
sample buffer. For MEK inhibition studies, haemocytes were
pre-incubated in either U0126 (0.001–10 AM), PD98059
(0.01–100 AM) or vehicle (methanol or DMSO, respectively)
for 30 min at room temperature prior to the addition of E. coli
LPS. Samples were either processed immediately for SDS-
PAGE and Western blotting, or were stored at  20 jC.
2.5. MAP kinase activity assay
Haemocyte monolayers were prepared in cell culture
plates and were treated as previously stated. Immunopre-
cipitation and ERK activity assays were carried out using
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instructions. Briefly, 200 Ag total haemocyte protein, deter-
mined using the Bio-Rad DC protein assay, was incubated
with 15 Al of immobilised anti-phospho p44/42 MAPK
antibody overnight at 4 jC with constant agitation. Immu-
nocomplexes were then incubated with ATP and an Elk
fusion protein for 1h at 30 jC and the reaction stopped by
the addition of SDS-PAGE sample buffer. Since the Elk
fusion protein is phosphorylated by phospho-ERK 1/2,
Western blotting with anti-phospho Elk-1 antibody reveals
which samples possess ERK activity.
2.6. Western blotting
Samples containing equal amounts of protein were load-
ed onto a discontinuous SDS-PAGE slab gel, which
contained 10% acrylamide in the resolving gel. After
electrophoresis, proteins were electro-blotted onto Hybond
nitrocellulose membrane (0.2 Am), using a semi-dry transfer
unit, and homogeneous transfer was confirmed by staining
with Ponceau S. Membranes were then blocked for 1 h at
room temperature with 5% (w/v) non-fat dry milk in Tris-
buffered saline containing 0.1% (v/v) Tween-20 (TTBS).
Membranes were incubated overnight at 4 jC in anti-
phospho-p44/42 MAPK (1:1000), anti-p44/42 MAPK
(1:1000), anti-phospho-MEK 1/2 (1:1000) or anti-phos-
pho-Elk 1 (1:1000) primary antibodies. Immunoreactive
proteins were then visualised, after exposure to horseradish
peroxidase-conjugated secondary antibody for 1 h at 25 jC,
with the Opti-4CN detection kit. No signal was detected
following incubation of the membrane in secondary anti-
body alone. Where appropriate, the intensity of the signal
was analysed using Kodak 1D image analysis software.
2.7. Immunocytochemistry
Haemocytes were allowed to adhere to cover slips for 30
min at room temperature and the cover slips were then
washed with SSS three times. After equilibrating in SSS for
15 min, haemocytes were challenged with LPS with or
without U0126 (10 AM) as previously described. Haemo-
cytes were subsequently fixed and permeabilised with fixing
buffer (3.7% (v/v) formaldehyde, 0.18% (v/v) Triton X-100
in PBS) for 12 min at room temperature, and cover slips
blocked with BSA (1% (w/v) in PBS) for a further 12 min at
room temperature. Cells were then incubated with the anti-
phospho p44/42 MAPK antibody (1:150 in blocking buffer;
3 h), followed by a FITC-conjugated goat-anti-rabbit sec-
ondary antibody (1:150 in blocking buffer; 45 min) and
rhodamine phalloidin (0.1 Ag/ml; 40 min). All incubations
were performed at room temperature in humidified cham-
bers. Finally, cover slips were mounted onto slides with
Vectashield and were observed with a Zeiss Axiophot 20
photomicroscope using a triple filter; excitation wavelengths
were 410, 505 and 585 nm (with beamsplitters: 395, 485
and 560 nm; and barriers: 460, 530 and 610 nm, respec-tively). Images were digitally captured using a Nikon
DN100 camera linked to the Nikon Eclipse Net image
analysis package.
2.8. Phagocytosis assays
Haemocyte monolayers were prepared as previously
described in individual wells of a 96-well culture plate
(Nunc) and washed three times with SSS. Haemocytes
were then pre-incubated with MEK inhibitors U0126 (0–
100 AM) or PD98059 (0–100 AM), the PKC inhibitor,
GF109203X (10 AM) or the farnesylation inhibitor, FTase
inhibitor I (0–100 AM) for 30 min prior to the addition of
FITC-conjugated ‘‘bioparticles’’ (6 106 per well). After
the haemocytes had been challenged for 1 h at room
temperature in a dark chamber, the ‘‘bioparticles’’ were
removed and 2% (w/v) trypan blue was added to the
wells for 2 min to quench extracellular fluorescence.
Intracellular fluorescence was then quantified using a
Fluorstar optima spectrofluorometer (BMG Labtechnolo-
gies, Aylesbury, UK).
2.9. Statistical analysis
Where appropriate, results were analysed with one-way
ANOVA and post hoc multiple comparison tests (Tukey),
using the statistical software package SPSS.3. Results
3.1. Identification of L. stagnalis ERK
Western blot analyses were done on total haemocyte
protein extracts to identify ERK-like proteins in L. stagnalis
haemocytes. The use of two different primary antibodies,
the anti-phospho p44/42 MAP kinase antibody (NEB), and
the anti-active MAPK antibody (Promega), revealed the
presence of ERK-like proteins in an active state (Fig. 1).
Two bands were detected in the haemocyte samples with
apparent molecular weights of 44 and 43 kDa, although in
many experiments, the bands were indistinguishable, pre-
sumably migrating as one. Two bands of approximately 44
and 42 kDa were detected in NGF-treated PC12 cells as
expected. Since the anti-phospho p44/42 antibody (NEB)
seemed to be more effective at detecting haemocyte ERK,
this antibody was used for all further experiments. The anti-
pan-ERK antibody was also used to probe total haemocyte
protein extracts. Although this antibody is capable of
detecting all ERK isoforms (p42, p44, p56 and p85)
regardless of activation status in mammalian cells, only
proteins of 44 and 43 kDa were detected in L. stagnalis
haemocytes.
Western blotting with anti-p44/42 MAP kinase (NEB)
and anti-ERK 1/2 (Promega) antibodies to detect total ERK
protein levels, irrespective of phosphorylation status,
Fig. 2. Activation of ERK and MEK after challenge with 1 Ag/ml LPS.
Equal amounts of haemocyte proteins were probed with the anti-phospho
p44/42 MAP kinase antibody or anti-phospho MEK antibody to detect
changes in ERK and MEK phosphorylation with time (A, upper panel and
C, respectively). Total levels of ERK were also determined using the anti
p44/p42 MAP kinase antibody (A, lower panel). Immunoblots (n= 6) were
scanned and ERK phosphorylation levels determined by image analysis
(B); values shown are mean (F S.E.); *PV 0.05 when compared to control
(0 min) values; the MEK immunoblot is representative of two independent
experiments.
Fig. 1. Detection of ERK 1/2 in L. stagnalis haemocytes. Anti-active
MAPK (Promega) antibody was used to detect phosphorylated ERK in
haemocytes (c), untreated (a) and NGF-treated (b) PC12 cells were used
as controls. Haemocyte proteins (20 Ag) were also probed with the anti-
phospho p44/42 MAP kinase antibody (NEB) (d). Haemocyte proteins
(f, 20 Ag) were then probed for p42, p44, p56 and p85 ERK isoforms
with the anti-pan ERK antibody, RSV-3T3 cells (e) were used as a
control. Results are representative of three independent experiments.
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occasionally a second band was also present at 44 kDa.
3.2. The effect of LPS on ERK and MEK phosphorylation
levels
Western blotting was done with the anti-phospho p44/42
antibody to determine the activation status of ERK follow-
ing challenge of haemocytes with LPS. Initial experiments
with unchallenged haemocytes showed that basal levels of
phosphorylated ERK did not change after extraction, during
washing, or over an 80 min period after haemocyte adher-
ence (data not shown). Previous studies with both haemo-
cytes and mammalian macrophages have used cell-free LPS
concentrations of between 1 and 100 Ag/ml [7,8,21,28]. In
this study haemocytes were challenged with 1 Ag/ml LPS,
which resulted in increased ERK 1/2 phosphorylation. This
increase appeared as a transient response to the LPS over a
20-min time course, with maximal activation at 5 min post-
exposure and a return to basal level after 20 min (Fig. 2A).
Image analysis of blots confirmed that maximal activation
took place after 5 min LPS challenge and that the increase in
phosphorylation at this time point was significantly different
from control levels (P < 0.05; Fig. 2B). Total-ERK protein
levels were unchanged as a result of LPS challenge (Fig.
2A). Relatively high basal levels of phosphorylated ERK
were observed during some experiments, and in these cases
the increase in ERK phosphorylation following challenge
was less marked. These high basal levels of phosphorylation
were presumably a result of haemocyte extraction and celladhesion. The high basal levels of phospho-ERK could also
have been due to the activity of phosphatidylinositol-3-
kinase (PI-3-K), which is known to result in the activation
of the ERK pathway in fibroblasts and COS cells [31]. To
check whether this was occurring in haemocytes, LY294002
was pre-incubated with monolayers to prevent ATP binding
to the catalytic subunit of PI-3-K. The use of LY294002 did
not reduce ERK phosphorylation levels (results not shown),
suggesting that PI-3-K does not regulate basal ERK phos-
phorylation in haemocytes as it does in some vertebrate
cells.
A L. stagnalis haemocyte phospho-MEK-like protein,
with an apparent molecular weight of 43 kDa, was detected
with the use of the anti-phospho MEK 1/2 (NEB) antibody
that detects MEK when phosphorylated at Ser217/221 resi-
dues (Fig. 2C). This MEK-like protein was activated at
times corresponding to those for ERK activation, although
Fig. 3. Effect of MEK inhibition on ERK phosphorylation levels. Various
concentrations of the MEK inhibitors U0126 (0.001–10 AM, A) and
PD98059 (0.01–100 AM, B) were pre-incubated with haemocytes prior to
challenge with 10 Ag/ml LPS. Equal amounts of haemocyte proteins were
probed with the anti-phospho p44/p42 MAP Kinase antibody to determine
ERK phosphorylation in treated and control (vehicle, ‘c’) samples. The
immunoblot is representative of three independent experiments.
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tion following 5 min LPS stimulation were not significantly
different from control levels.
3.3. Inhibition of ERK phosphorylation with U0126 and
PD98059
To confirm thatMEK acts upstream of ERK in L. stagnalis
haemocytes, MEK inhibitors (U0126 and PD98059) were
used to block ERK activation prior to challenge with LPS.
U0126 is capable of inhibiting both MEK 1 and MEK 2
isozymes, while PD98059 is more potent towards MEK 1.
U0126 reduced the level of phosphorylated ERK in haemo-
cytes in a dose-responsive manner with 10 AM completely
blocking phosphorylation of the ERK-like protein (Fig. 3A).
PD98059 had a much less marked effect on ERK phosphor-
ylation (Fig. 3B). Total ERK expression levels did not change
in response to either inhibitor.
3.4. Non-radioactive MAP kinase activity assay
To check that the L. stagnalis ERK possessed kinase
activity, a MAP kinase activity assay was used. This assay
measured the extent of Elk-1 fusion protein phosphorylationFig. 4. Elk-1 fusion protein is phosphorylated by haemocyte ERK. The
positive control is shown in lane (a), whilst (b) shows Elk-1 fusion protein
phosphorylated by immunoprecipitated phospho-ERK from haemocytes
challenged with LPS (10 Ag/ml). No phospho-Elk 1 fusion protein was
detected when haemocytes were pre-incubated with U0126 prior to LPS
challenge (c). Results are representative of three independent experiments.
Fig. 5. Immunocytochemical analysis of phospho-ERK activation and
inhibition in haemocytes. Images show (A) levels of phosphorylated ERK
(green fluorescence) in non-treated cells, (B) in haemocytes challenged with
LPS (10 Ag/ml), and (C) in haemocytes pre-incubated with U0126 (10 AM)
prior to challenge. Cells were fixed and permeabilised as described in
Materials and methods. Anti-phospho p44/p42 MAP kinase primary
antibody was used in conjunction with FITC-conjugated secondary
antibody. Filamentous actin fluoresces red with 0.1 Ag/ml rhodamine
phalloidin. Results are representative of two independent experiments. (For
color see online version).
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phospho-ERK immunoprecipitates. The phosphorylated Elk-
1 fusion protein appeared as an immunoreactive band of 41
kDa as expected in control (cell lysate with 20 ng purified
ERK 1/2) samples (Fig. 4). Haemocyte samples challenged
with 10 Ag/ml LPS showed kinase activity towards the Elk-1
fusion protein. Non-stimulated haemocyte samples also
showed relatively high kinase activity reflecting the high
basal levels seen in previous experiments (results not shown).
Assays with extracts from haemocytes incubated with the
MEK inhibitor, U0126, prior to challenge had no detectable
phosphorylated Elk-1 fusion protein present following West-
ern analysis (Fig. 4) due to inhibition of any basal and LPS-
stimulated activity. This agrees with the result of dose–
response experiments with U0126, in which 10 AM appeared
to completely abolish ERK activation.
3.5. Immunocytochemistry
Phosphorylated ERK was visualised by immunocyto-
chemistry to determine its cellular location before and after
challenge. When cells were stimulated with 10 Ag/ml LPS for
5 min the level of phosphorylated ERK increased in theFig. 6. Blockade of haemocyte phagocytic activity by MEK, PKC and farnesylat
U0126 and PD98059 (C) and FTase inhibitor I (D), or vehicle (shown as control
‘‘bioparticles’’. Uptake of ‘‘bioparticles’’ by haemocytes was then assessed by s
**PV 0.001 when compared to control values.cytoplasm, particularly in the perinuclear regions, with a
diffuse activated ERK signal within the nucleus (Fig. 5A
and B). When cells were treated with U0126 (10 AM),
inhibition of ERK phosphorylation after LPS treatment was
clearly seen (Fig. 5C).
3.6. Inhibition of phagocytosis with U0126, PD98059,
GF109203X and FTase inhibitor I
The ability of MEK (U0126 and PD98059), PKC
(GF109203X) and farnesylation (FTase inhibitor I) inhib-
itors to affect phagocytosis of fluorescent ‘‘bioparticles’’
was tested. Analysis of variance revealed that U0126
blocked phagocytosis in a dose-dependent manner with
100 AM U0126 significantly reducing mean phagocytic
activity by approximately 80% compared to the control
(P < 0.001; Fig. 6A). When used at a similar concentration,
PD98059 also significantly reduced phagocytosis, but the
effects of this inhibitor were less marked (25% reduction in
phagocytic activity, P < 0.05; Fig. 6B). Although a relatively
high concentration of PD98059 (100 AM) was used in this
study, similar and higher concentrations have been used by
other workers [25].ion inhibitors. U0126 (A), PD98059 (B), GF109203X in combination with
s), were pre-incubated with haemocytes prior to challenge with fluorescent
pectrofluorometry. Values shown are mean (F S.E.; n= 6). *PV 0.05 and
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significantly reduced mean phagocytic activity by 43%
compared to the control (P < 0.001; Fig. 6C). GF109203X
and the twoMEK inhibitors were then used in combination to
further dissect the role of signalling components in phago-
cytosis by L. stagnalis haemocytes. Although PD98059 (100
AM) and GF109203X (10 AM) together reduced mean
phagocytic activity by 56%, the effect of combined inhibitor
use was not significantly different from the reductions in
phagocytic activity seen with GF109203X (10 AM) alone
(Fig. 6C). This is in contrast to the combined use of
GF109203X (10 AM) and U0126 (100 AM) which signifi-
cantly reduced phagocytosis by a further 14% when com-
pared to GF109203X (10 AM). The use of this combination of
inhibitors also appeared to have a dose-responsive effect on
phagocytosis with increasing concentration of U0126 caus-
ing an apparent decrease in phagocytic activity (39% and
64% reductions for 10 and 100 AM GF109203X, respective-
ly, when compared to the control; PV 0.05). This effect is in
agreement with the dose-responsive effect of U0126 when
used alone (Fig. 6A).
The use of FTase inhibitor I, which blocks farnesylation
of the upstream MAPK component Ras, resulted in a dose-
responsive reduction in phagocytosis (Fig. 6D). At 50 and
100 AM, mean phagocytic activity by haemocytes was
reduced by 25% and 39%, respectively, when compared to
control, with a significant difference in phagocytosis ob-
served with the higher concentration (P < 0.05).4. Discussion
The signal transduction pathways of invertebrate haemo-
cytes have been largely overlooked until recently when
workers have begun to study signalling in insect and
mollusc haemocytes [21–26,28,32]. The present study
reports the first identification of ERK-like immunoreactive
proteins in primary haemocytes from the gastropod mollusc,
L. stagnalis. The ERK isozymes have apparent molecular
weights of 44 and 43 kDa and their kinase activity has been
confirmed with an ERK activity assay.
L. stagnalis ERK was phosphorylated when the cells
were challenged with E. coli LPS, with a transient activa-
tion occurring over a 20 min post-exposure period. The
phosphorylation of ERK appeared greatest at 5 min, which
indicates that the cells act relatively quickly to the presence
of bacterial components. The activation of ERK has
previously been reported in haemocytes from C. capitata
when challenged with E. coli LPS [21], and in mammalian
macrophages following challenge with bacteria [5,6], with
similar temporal, transient patterns of phosphorylation.
Since macrophages and haemocytes are functionally sim-
ilar [4], the comparable responses of the ERK pathway to
LPS challenge between these cells suggest that ERK
signalling in innate immunity may have been conserved
through evolution.Immunocytochemical studies with L. stagnalis haemo-
cytes demonstrated that phosphorylated ERK was present as
a diffuse signal in the nucleus following challenge. The
presence of active ERK in the nucleus has been shown for
many cell types due to various transcription factors being
targets of phospho-ERK isozymes [17]. Levels of phospho-
ERK also increased within the cytoplasm after 5 min expo-
sure to LPS, particularly in the perinuclear region. One
possible explanation for the clustering appearance of phos-
pho-ERK in the cytosol could be the binding of ERK to FAK/
Src complexes associated with focal adhesion sites. Activa-
tion of FAK has been shown to lead to ERK phosphorylation
in many cell types [33–35] and MEK kinase (Raf) has been
shown to interact with FAK in mouse fibroblasts [36]. The
importance of the Src-family kinases, Hck and Fgr, in integrin
signalling by macrophages has been demonstrated by Suen et
al. [37]. The FAK/Src complex has been reported in insect
haemocytes and is activated through the h3 integrin subunit
when challenged with E. coli, the blocking of FAK activity
also prevents phagocytosis [22]. h integrin subunits also exist
in Bge cells [26]. Given these findings, a study of FAK/Src
complexes and their role in ERK signalling in molluscan
haemocytes warrants further investigation.
When haemocytes were pre-incubated with the MEK
inhibitor U0126, phosphorylated ERK was not present in
the nucleus, however, some clustering of phospho-ERK still
appeared within the cytoplasm. Although de novo MEK
phosphorylation would be blocked by U0126, existing active
MEK may still be present in the cytosol and may be
responsible for the residual activation of ERK following
challenge.
Since activation of the ERK pathway plays a key regu-
latory role in immune responses by mammalian macro-
phages [5–10], this study also set out to establish whether
this was true for L. stagnalis haemocytes. By inhibiting both
MEK isozymes (MEK 1/2) with U0126, haemocyte phago-
cytic activity was blocked to a greater extent than by
blocking just MEK 1 alone with PD98059. In Western
blotting experiments, U0126 was more effective at blocking
ERK phosphorylation than PD98059. In fact, the inhibition
of MEK 1/2 with U0126 had the greatest effect on phago-
cytosis of all the inhibitors used (PD98059, FTase inhibitor I
and GF109203X). The finding that different doses of U0126
were required to block ERK phosphorylation (10 AM) and
phagocytosis (100 AM) is probably a consequence of
differing incubation periods and/or internalisation of differ-
ent agents, cell-free LPS and bioparticles, respectively. The
limited effect of PD98059 on phagocytic activity suggests
that both MEK isozymes are required for efficient phago-
cytosis by L. stagnalis haemocytes. Canesi et al. [23] have
also reported a similar response to PD98059 in haemocytes
from M. galloprovincialis, further supporting the possibility
that in molluscan haemocytes, ERK-dependent phagocyto-
sis relies heavily on MEK 2 activation. When GF109203X
was combined with U0126, phagocytosis was blocked to a
greater extent than by GF109203X alone, suggesting that
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phagocytosis. While such pathways seem to play a signif-
icant role in phagocytosis by molluscan haemocytes, clearly
they may be stimulated by compounds other than LPS on
the bacterial surface.
To target the upstream regulator of the MAPK cascade,
Ras, and to study its effect on phagocytosis, haemocytes
were treated with the Ras farnesylation inhibitor, FTase
inhibitor I. Farnesylation of Ras increases its hydrophobicity
and encourages its movement to the plasma membrane,
where phosphorylation occurs. Humphries et al. [25] have
shown that this inhibitor reduces Bge cell spreading when
used at the same concentrations as those used in the present
study. By inhibiting Ras activation, the phagocytic activity
of L. stagnalis haemocytes was significantly reduced, but to
a lesser extent than by inhibiting MEK isozymes directly.
This suggests that activation of the ERK pathway in L.
stagnalis haemocytes can occur through both Ras-indepen-
dent and -dependent mechanisms. Ras-independent mecha-
nisms could involve PKA acting positively or negatively on
Raf as has been shown in various cell types [38–42]. In
addition, with use of PKA inhibitors, Lacoste et al. [43]
have shown that PKA is involved in phagocytosis by
haemocytes from the oyster, Crassostrea gigas, when the
cells are challenged with noradrenaline.
In this study E. coli LPS, ‘‘bioparticles’’ and freshly
extracted primary haemocytes from L. stagnalis were used
as a model system to explore the regulation of the ERK
signalling pathway following challenge and the role of this
pathway in phagocytosis. The presence of ERK pathway
components in these cells have been demonstrated and it has
been shown that ERK activation is necessary for efficient
phagocytosis of ‘‘bioparticles’’ by haemocytes. As L. stag-
nalis is a host to the avian schistosome Trichobilharzia
ocellata, we intend to extend our studies with primary
haemocytes to the investigation of cell signalling in host–
parasite relationships. Many studies, such as one focusing on
B. glabrata and Echinostoma caproni [44], have shown that
parasites survive by switching off host immune defences.
Clearly it would be interesting to see whether signalling
pathways involved in phagocytosis by haemocytes are
down-regulated when snails are challenged with parasites
or parasite extracts.Acknowledgements
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